1. Introduction {#sec1-ijerph-16-01711}
===============

According to the World Health Organization, stress has become a serious global health risk in modern, urban daily life \[[@B1-ijerph-16-01711]\]. Since over half the world's population now lives in urban areas, it is vital to find ways of promoting stress recovery in daily life \[[@B2-ijerph-16-01711]\]. One method that is receiving increased attention is spending time in nature. Natural environments are today acknowledged as an important public health resource for promoting stress recovery and general well-being \[[@B3-ijerph-16-01711],[@B4-ijerph-16-01711]\].

The research has mainly come from European and North American research institutions. However, more and more studies are being carried out in Asian countries, especially Japan and South Korea, where the concept of shinrin-yoku ('forest bathing'), first proposed in 1982, is becoming increasingly popular and scientifically recognized \[[@B5-ijerph-16-01711]\].

Several recent reviews have been conducted on the health benefits of nature, focusing on various health-related parameters and environments \[[@B6-ijerph-16-01711],[@B7-ijerph-16-01711],[@B8-ijerph-16-01711],[@B9-ijerph-16-01711],[@B10-ijerph-16-01711]\]. A review by McMahan and Estes \[[@B6-ijerph-16-01711]\] included measures of negative and positive affect in a broad range of natural environments, while Haluza, Schönberger, and Cervinka focused physiological effects \[[@B7-ijerph-16-01711]\]. A review by Kondo, et al. \[[@B8-ijerph-16-01711]\] included all outdoor environments, not just natural environments, while James, et al. alone focused on neighborhood greenness \[[@B9-ijerph-16-01711]\]. A review by Twohig--Bennet and Jones (2018) \[[@B10-ijerph-16-01711]\] included both observational and interventional studies as well as a broad range of health-related measures. The reviews adjoin and overlap with one another even though each is unique in scope, contributing to an increasingly comprehensive understanding of the possible health effects of human--nature interactions. Overall, they find positive associations between natural environments and various aspects of human health. However, they also reach similar conclusions to the effect that the evidence base remains limited by study designs and/or high levels of heterogeneity.

The present review seeks to provide an overview of the past eight years' research into psycho-physiological effects, related to stress recovery, of outdoor green nature exposure. The rationale for the limited time frame was mainly directed by limited resources (funding), and the specific timeframe was chosen because the last review of the psychological and physiological effects of nature exposure was published by Bowler et al. \[[@B11-ijerph-16-01711]\] in 2010. However, it should be highlighted that the present review is not a direct continuation of the review by Bowler et al., which compared the effects of natural environments with those of synthetic environments and had a boarder scope concerning health.

1.1. Psychological and Physiological Stress Recovery {#sec1dot1-ijerph-16-01711}
----------------------------------------------------

Stress arousal is human beings' natural response to a strain that is appraised as potentially threatening and that gives rise to negative emotions \[[@B12-ijerph-16-01711]\]. The appraised threat starts a cascade of physiological responses to mobilize energy: steroid hormones are released in the endocrine system, and the sympathetic nervous system is activated, which affects cardiovascular functioning and increases heart rate and perspiration \[[@B13-ijerph-16-01711]\].

According to Roger Ulrich's environmental and psycho-psychological stress recovery theory \[[@B14-ijerph-16-01711]\], stress recovery involves both physiological and physiological components. Physiological recovery entails a shift to parasympathetic nervous activity, which sustains the organism's healthy functions in the cardiovascular, endocrine, and immune system, whereas psychological recovery entails a positive change in emotional state.

Recovery of cognitive functioning, as set forth in Steven and Rachel's Attention Restoration Theory \[[@B15-ijerph-16-01711]\], can also be seen as related to stress recovery. However, as the latest reviews on the cognitive effects of natural environments have been published quite recently \[[@B16-ijerph-16-01711],[@B17-ijerph-16-01711]\], it was decided not to include this dimension in the present review and to instead focus on psychological and physiological aspects of stress recovery.

1.2. Research Questions {#sec1dot2-ijerph-16-01711}
-----------------------

What is the latest evidence base for psychological effects, related to stress recovery, by nature exposure?

What is the latest evidence base for physiological effects, related to stress recovery, by nature exposure?

2. Method {#sec2-ijerph-16-01711}
=========

The methodology of the systematic review followed the guidelines set forth in the Preferred Reporting Items for Systematic Review and Meta-Analysis Protocols (PRISMA-P) \[[@B18-ijerph-16-01711]\]. The PICO (Population/Problem, Intervention, Comparison, Outcome) framework ([Table 1](#ijerph-16-01711-t001){ref-type="table"}) was used to clarify the objectives of the review and facilitate the search strategy. (The full protocol in Danish can be acquired by contacting the corresponding author.)

2.1. Eligibility Criteria {#sec2dot1-ijerph-16-01711}
-------------------------

We decided to include both randomized controlled trials (RCT) and non-randomized controlled trials. The rationale behind this decision was that the field largely still consists of non-randomized trials, and excluding non-RCT studies might thus result in an incomplete summary of the status. This is a common approach in reviews, although one should be aware of the greater risk of bias in the non-RCT studies \[[@B19-ijerph-16-01711]\] due to the less rigorous study design.

The language was limited to English and the research to peer-reviewed studies published between January 2010 and March 2018. These limitations were mainly directed by limited resources (funding, time, and translators). Limitations concerning language and peer-reviewed studies are common in reviews, but they subject the results to limitations and potential biases \[[@B20-ijerph-16-01711]\], which will be discussed in the limitations section.

To be eligible, the studies should have adult informants without mental disabilities or serious physical or mental illnesses not related to stress. The exposure should take place outdoors in natural green environments, whether in urban gardens and parks or in more remote and unspoiled areas such as forests, mountains, grasslands, and beaches. It was decided to include only outdoors nature-based interventions to obtain some consistency across studies on the environmental variable. Further studies comparing, for example, real nature and lab stimulation thereof have obtained heterogeneous results \[[@B21-ijerph-16-01711],[@B22-ijerph-16-01711]\], which calls into question the transferability of results between the two settings. The same rationale of consistency in the environmental variable also led to the exclusion of blue environments such as the sea, lakes, and rivers. Only studies with sedentary and light physical activity were included, as vigorous physical exercise, such as running or mountain biking, have been found to have psychological and physiological effects in themselves \[[@B23-ijerph-16-01711]\].

To be eligible, the studies needed to entail psychological effect measures in terms of measuring changes in emotional states and/or physiological effect measures in terms of measuring changes in cardiovascular, endocrine, and/or immune functioning, in accordance with the stress recovery theory (SRT) \[[@B14-ijerph-16-01711]\]. Studies only using outcome measures, not validated through research, concerning their psychometric properties \[[@B24-ijerph-16-01711]\], were excluded. If a study entailed both validated and non-validated outcome measures, it was included, and only the validated measures were reported in the review.

2.2. Information Source and Search Strategy {#sec2dot2-ijerph-16-01711}
-------------------------------------------

A structured search was performed in the following seven databases: PUBMED, Web of Science, PsycInfo, SCOPUS, ASSIA, CINAHL, and Cocraine. The search took place in April 2018. The search string used OR to search for different physiological and psychological outcomes and different nature-based interventions respectively.

Outcome measures of emotional states, related to stress recovery, were operationalized into the following search terms: stress OR recovery OR health OR restorat OR well-being OR {well being} OR wellbeing OR well-being OR burnout OR fatigue OR emotion\* OR affect\* OR feeling\* OR mood OR relax\*. Outcome measures of cardiovascular, endocrine, and/or immune functioning were operationalized into the following search terms: cardiovascular OR {blood pressure} OR heartrate OR {heart rate} OR endocrine OR immune OR physiological\* OR cortisol OR noradrenaline OR adrenaline OR dopamine.

The possible outcomes were combined with possible outdoors nature-based interventions in the search string by AND.

Search terms for outdoors green nature-based interventions were natur\* OR green OR outdoor OR forest OR wilderness OR wood\* OR garden OR park OR horticultur\* OR {open space\*} OR vegetation\* OR seaside OR {sea side}.

When possible, depending on the individual search engine, the subject was limited to human and the areas to psychology, social sciences, nursing, arts and humanities, medicine, multidisciplinary research, and health professions.

2.3. Inclusion and Assessment {#sec2dot3-ijerph-16-01711}
-----------------------------

The identified articles were screened for eligibility by title and, in case of doubt, by reading the abstract. Assessment of the included studies was based on the quality assessment tool for quantitative studies developed by the Effective Public Health Practice Project (EPHPP) \[[@B25-ijerph-16-01711]\]. This instrument provides an overall methodological rating of studies as strong, moderate, or weak based on eight parameters: selection bias, study design, confounders, blinding, data collection methods, withdrawals and dropouts, intervention integrity, and analysis. The parameters are individually rated as strong, moderate, or weak. If a study has two or more weak ratings in the parameters, it is considered weak overall. Studies with only one weak rating are considered moderate, and only studies with no weak ratings are considered strong. The tool has been evaluated for construct validity and inter-rater reliability \[[@B26-ijerph-16-01711]\]. Each study was assessed independently by two researchers using the EPHPP tool. The individual assessments were discussed between the research team (authors), and a final rating was granted to each study based on agreement between researchers. In order to handle possible duplicates, it was decided that if the same study was reported in several papers, the papers would be included if they involved different effect measures related to the scope of the review. In case of duplication of results, only the results from the first-published paper would be included.

3. Results {#sec3-ijerph-16-01711}
==========

3.1. Article Selection Process {#sec3dot1-ijerph-16-01711}
------------------------------

The database search returned 5618 articles. Removal of duplicates and initial screening gave a total of 95 studies. After full-text reading, 59 studies were excluded, and 36 studies were included in the assessment and synthesis ([Figure 1](#ijerph-16-01711-f001){ref-type="fig"}).

3.2. Characteristics of Included Studies {#sec3dot2-ijerph-16-01711}
----------------------------------------

[Table 2](#ijerph-16-01711-t002){ref-type="table"} summarizes the characteristics of the included studies: country of origin, study design, sample size and characteristics, type of intervention and control, time duration, and quality assessment.

### 3.2.1. Study Design and Quality Assessment {#sec3dot2dot1-ijerph-16-01711}

Three studies were conducted as randomized controlled trials, with one being a crossover RCT. In the quality assessment, two of the studies were assessed as moderate and one was assessed as weak. Seventeen of the studies were categorized as controlled clinical trials (CCT), and nine of these had crossover designs. Five of the studies were assessed as weak, and three were assessed as moderate in quality. Sixteen studies had pre-post designs, with five including a control group and three in the form of a crossover design ([Table 2](#ijerph-16-01711-t002){ref-type="table"}). Only one of the pre-post studies was assessed as moderate in the quality assessment; the remaining fifteen studies were assessed as weak.

None of the included studies were considered strong overall according to the EPHPP quality assessment ([Table 2](#ijerph-16-01711-t002){ref-type="table"}, last column). This was due to several recurring weak ratings in the parameters: lack of information on recruitment procedure and/or using self-referred individuals as a sample (selection bias), lack of information on withdrawals and dropouts (withdrawals and dropouts), and not including comprehensive background information on the subjects (confounders). The issue of potential confounders in the EPHPP relates to relevant confounders between groups. In the studies with no control group or a crossover design, we modified the questions to concern the level of background information on the single group. Furthermore, none of the studies provided information on blinding of either assessors or informants. The parameter concerning blinding of informants to the research question might not be applicable in studies with multiple environmental exposures. However, the parameter is relevant to the blinding of the assessors. To allow for an alternative assessment of the blinding parameter issues, we carried out a second overall quality assessment excluding this parameter ([Table 2](#ijerph-16-01711-t002){ref-type="table"}, last column).

### 3.2.2. Location {#sec3dot2dot2-ijerph-16-01711}

Most of the studies were conducted in Europe (14) and Asia (14), followed by the USA (6), Canada (1), and Australia (1). A variety of European countries were represented by one study each (Denmark, Iceland, Finland, Ireland, Germany, the Netherlands, Austria, and Lithuania), two studies were from Sweden, and four studies were from the UK. In Asia, Japan was represented with nine studies, making it by far the single most-represented country in the review. South Korea, China, and Taiwan were each represented with one study ([Table 2](#ijerph-16-01711-t002){ref-type="table"}).

### 3.2.3. Sample Characteristics {#sec3dot2dot3-ijerph-16-01711}

The sample sizes varied widely, ranging from 9 to 935 subjects in the RCTs, 9 to 418 subjects in the CCTs, and 10 to 50 subjects in the pre-post studies ([Table 2](#ijerph-16-01711-t002){ref-type="table"}). Great variation was also found in sample populations, which included office workers; allotment gardeners; veterans; elderly subjects; and subjects with specific mental and physical illnesses related to stress, depression, and cardiovascular disease. The most common sample consisted of university students (10). Most studies included both sexes as subjects (22).

### 3.2.4. Environments and Activities {#sec3dot2dot4-ijerph-16-01711}

The most common research setup entailed comparing an intervention in a natural environment, forest, or park to an intervention in an urban environment, mainly in city centers (12). The most common activity was walking and/or sitting (22). A few studies involved other activities such as gardening \[[@B30-ijerph-16-01711],[@B37-ijerph-16-01711],[@B54-ijerph-16-01711]\] and relaxation exercises in nature \[[@B53-ijerph-16-01711],[@B54-ijerph-16-01711],[@B59-ijerph-16-01711],[@B60-ijerph-16-01711]\]. The durations of the interventions differed substantially and were spread between 15 and 55 min (14), one to several hours (3), one to several days (8), one to several weeks (3), and months (8) ([Table 2](#ijerph-16-01711-t002){ref-type="table"}).

3.3. Summary and Synthesis of Psychological Outcomes {#sec3dot3-ijerph-16-01711}
----------------------------------------------------

The heterogeneous data, wide range of interventions and study designs, generally low quality of studies (low: 31, moderate: 5, strong: 0), and recurring missing information in the results sections made the studies unsuitable for pooling for meta-analysis \[[@B63-ijerph-16-01711]\]. The findings were therefore first summarized and then compared in a narrative synthesis \[[@B64-ijerph-16-01711]\]. This was done separately for the psychological and physiological measures. An overview of the physiological measures and findings is presented in [Table 3](#ijerph-16-01711-t003){ref-type="table"}.

### 3.3.1. Stress, Burnout, and Recovery Outcomes {#sec3dot3dot1-ijerph-16-01711}

Eight studies included measures of the level of self-perceived stress ([Table 3](#ijerph-16-01711-t003){ref-type="table"}). Four studies found a significant difference between the intervention and control, in favor of the natural environment (nature ˃ control) \[[@B31-ijerph-16-01711],[@B33-ijerph-16-01711],[@B42-ijerph-16-01711],[@B51-ijerph-16-01711]\], with significance levels between *p* ˂ 0.05--0.001. Three of the studies were CCTs. Two pre-post studies without control groups found no significant decrease from before to after the intervention \[[@B53-ijerph-16-01711],[@B54-ijerph-16-01711]\]. There was an effect of condition (nature ˃ control) in the CCT study that included a stress recovery measure \[[@B46-ijerph-16-01711]\].

### 3.3.2. Emotional Outcomes {#sec3dot3dot2-ijerph-16-01711}

In the studies including measures of positive and negative affect ([Table 4](#ijerph-16-01711-t004){ref-type="table"}), eight studies---four of them CCTs---found a positive significant difference in the pre-post measures of the intervention \[[@B36-ijerph-16-01711],[@B37-ijerph-16-01711],[@B38-ijerph-16-01711],[@B46-ijerph-16-01711],[@B47-ijerph-16-01711],[@B51-ijerph-16-01711],[@B53-ijerph-16-01711],[@B56-ijerph-16-01711]\], and two studies---one RCT and one pre-post without control group---found no significant difference in the pre-post measures of the intervention \[[@B27-ijerph-16-01711],[@B55-ijerph-16-01711]\].

Seven studies---four CCTs and three pre-post---found positive significant differences in pre-post measures of total mood disturbance or on subscales \[[@B29-ijerph-16-01711],[@B32-ijerph-16-01711],[@B34-ijerph-16-01711],[@B45-ijerph-16-01711],[@B48-ijerph-16-01711],[@B58-ijerph-16-01711],[@B59-ijerph-16-01711]\]. Two CCT studies found positive significant differences in both the intervention and control \[[@B34-ijerph-16-01711],[@B41-ijerph-16-01711]\]. Two studies---one CCT and one pre-post---found no significant difference in the pre-post measures \[[@B39-ijerph-16-01711],[@B54-ijerph-16-01711]\]. Of the three studies using anxiety measures, three found a significant decrease from the intervention \[[@B29-ijerph-16-01711],[@B61-ijerph-16-01711],[@B62-ijerph-16-01711]\] and one found a significant difference between intervention and control \[[@B44-ijerph-16-01711]\].

The five studies including measures of depression \[[@B50-ijerph-16-01711],[@B51-ijerph-16-01711],[@B55-ijerph-16-01711],[@B61-ijerph-16-01711]\] were all pre-post studies. Three of the studies reported a significant decrease from the intervention (nature ˃ control) \[[@B50-ijerph-16-01711],[@B51-ijerph-16-01711],[@B61-ijerph-16-01711]\], with significance levels of *p* \< 0.001--0.001. One pre-post study with a combined depression, anxiety, and stress scale also found a significant decrease from the intervention \[[@B52-ijerph-16-01711]\].

3.4. Well-Being, Quality of Life, and Mental Health Outcomes {#sec3dot4-ijerph-16-01711}
------------------------------------------------------------

Five studies included measures related to well-being, quality of life, and mental health ([Table 4](#ijerph-16-01711-t004){ref-type="table"}). Four reported significant increases from the intervention \[[@B54-ijerph-16-01711],[@B56-ijerph-16-01711],[@B57-ijerph-16-01711],[@B61-ijerph-16-01711]\], with significance levels of *p* ˂ 0.001--0.000, and one study found no significant effect \[[@B54-ijerph-16-01711]\].

### 3.4.1. Synthesis of Psychological Outcomes {#sec3dot4dot1-ijerph-16-01711}

The most studied psychological outcomes were related to different measures of emotional change ([Figure 2](#ijerph-16-01711-f002){ref-type="fig"}). Eighteen studies \[[@B29-ijerph-16-01711],[@B32-ijerph-16-01711],[@B34-ijerph-16-01711],[@B36-ijerph-16-01711],[@B37-ijerph-16-01711],[@B38-ijerph-16-01711],[@B44-ijerph-16-01711],[@B48-ijerph-16-01711],[@B50-ijerph-16-01711],[@B51-ijerph-16-01711],[@B53-ijerph-16-01711],[@B56-ijerph-16-01711],[@B58-ijerph-16-01711],[@B61-ijerph-16-01711],[@B62-ijerph-16-01711]\], including one RCT and eight CCTs, found positive significant difference on different measures of emotional change (significance levels *p* \< 0.05--0.001), whereas only four studies \[[@B27-ijerph-16-01711],[@B39-ijerph-16-01711],[@B54-ijerph-16-01711],[@B55-ijerph-16-01711]\] found no significant differences in the pre-post measures. This points towards a coherent and largely unambiguous evidence base of the past eight years of nature-based interventions as having a positive effect on various emotional parameters related to stress recovery. The evidence base concerning perceived stress level measures is weaker, though mainly positive. Four of the five studies that found a significant decrease had a CCT design \[[@B31-ijerph-16-01711],[@B33-ijerph-16-01711],[@B42-ijerph-16-01711],[@B46-ijerph-16-01711]\], which has greater weight than the three pre-post studies without control groups that did not find significant changes \[[@B53-ijerph-16-01711],[@B54-ijerph-16-01711],[@B61-ijerph-16-01711]\]. The lack in evidence base is therefore mostly due to the low number of studies and generally low significance levels (31,33,42: *p* \< 0.01--0.05). The effects on well-being and quality of life had high significance levels in the five measures showing positive significant increase (*p* \< 0.001--0.000) \[[@B54-ijerph-16-01711],[@B56-ijerph-16-01711],[@B57-ijerph-16-01711],[@B61-ijerph-16-01711]\], and two of the studies also had large sample sizes (57: sample size 195; 56: sample size 935). However, these lacked control groups, which weakens the results. The evidence base for this aspect can therefore be regarded as promising, though lacking studies with control groups.

3.5. Summary and Synthesis of Physiological Outcomes {#sec3dot5-ijerph-16-01711}
----------------------------------------------------

The findings are first summarized for the individual measures and then compared in a narrative synthesis \[[@B63-ijerph-16-01711]\]. An overview of the physiological measures and findings is presented in [Table 4](#ijerph-16-01711-t004){ref-type="table"}.

### 3.5.1. Endocrine Outcomes {#sec3dot5dot1-ijerph-16-01711}

Ten studies, including one RCT and six CCTs, reported a significant decrease in cortisol levels and other stress hormones after the intervention \[[@B28-ijerph-16-01711],[@B30-ijerph-16-01711],[@B37-ijerph-16-01711],[@B39-ijerph-16-01711],[@B41-ijerph-16-01711],[@B43-ijerph-16-01711],[@B46-ijerph-16-01711],[@B48-ijerph-16-01711],[@B58-ijerph-16-01711],[@B59-ijerph-16-01711]\] ([Table 4](#ijerph-16-01711-t004){ref-type="table"}). They all had low significance levels: *p* ˂ 0.05--0.01. Three of the CCT studies also found a significant decrease in the pre-post measures of the control exposure \[[@B37-ijerph-16-01711],[@B39-ijerph-16-01711],[@B46-ijerph-16-01711]\]. Four studies found no significant difference in the pre-post measures of the intervention \[[@B27-ijerph-16-01711],[@B32-ijerph-16-01711],[@B34-ijerph-16-01711],[@B49-ijerph-16-01711]\]. The studies that compared the effect of the intervention to that of the control also showed divergent results: three of the studies, all CCTs, found no significant difference \[[@B31-ijerph-16-01711],[@B41-ijerph-16-01711],[@B45-ijerph-16-01711]\], whereas three studies, two of which were CCTs, found a significant difference in favor of the intervention \[[@B40-ijerph-16-01711],[@B44-ijerph-16-01711],[@B50-ijerph-16-01711]\].

The use of cortisol as a measurement instrument was applied inappropriately in two of the studies \[[@B28-ijerph-16-01711],[@B30-ijerph-16-01711]\], as it only was measured twice (pre-post) in interventions spanning 10 weeks \[[@B30-ijerph-16-01711]\] and three months \[[@B28-ijerph-16-01711]\], respectively. Pre-post cortisol measures are only appropriate for assessing acute responses to stress in short interventions or in interventions with long time spans to establish a pattern in cortisol levels by repeated measures several times a day over a number of days to achieve a reliable estimate \[[@B64-ijerph-16-01711]\].

### 3.5.2. Cardiovascular Outcomes {#sec3dot5dot2-ijerph-16-01711}

Nine studies used heartrate variability as a measure of cardiovascular change ([Table 4](#ijerph-16-01711-t004){ref-type="table"}). One CCT study found a significant change in the pre-post measures of the intervention \[[@B43-ijerph-16-01711]\], and three studies---one CCT and two pre-post with control groups---found a significant difference between groups in favor of the intervention \[[@B40-ijerph-16-01711],[@B44-ijerph-16-01711],[@B50-ijerph-16-01711]\]. Two CCT studies found positive significant differences of both intervention and control as well as no difference between groups \[[@B41-ijerph-16-01711],[@B45-ijerph-16-01711]\]. Two studies found no significant differences \[[@B39-ijerph-16-01711],[@B62-ijerph-16-01711]\]. An inappropriate use of the HRV (heart rate variability) measure was detected in one study \[[@B50-ijerph-16-01711]\], in which the HRV post measures were collected a week after the intervention ended (six-week intervention with lunch break walk, with non-stressed university students as subjects).

Seven studies, including one RCT, found a significant decrease in intervention pre-post measures of blood pressure \[[@B27-ijerph-16-01711],[@B41-ijerph-16-01711],[@B45-ijerph-16-01711],[@B49-ijerph-16-01711],[@B58-ijerph-16-01711],[@B60-ijerph-16-01711],[@B62-ijerph-16-01711]\]. However, two of these studies---CCTs---also found a significant decrease in the control group and no significant difference between groups \[[@B41-ijerph-16-01711],[@B45-ijerph-16-01711]\], while three of the studies lacked a control group \[[@B58-ijerph-16-01711],[@B60-ijerph-16-01711],[@B62-ijerph-16-01711]\]. Two studies found no significant decrease in the pre-post measures of the intervention \[[@B34-ijerph-16-01711],[@B48-ijerph-16-01711]\]. The significance levels were low in all the studies (*p* ˂ 0.05--0.01).

The six studies that included pulse rate measures also showed divergent results: two studies without control groups found a significant decrease \[[@B58-ijerph-16-01711],[@B62-ijerph-16-01711]\], whereas one study found no significant effect \[[@B60-ijerph-16-01711]\]. Two CCT studies found a difference between groups in favor of the natural environment \[[@B34-ijerph-16-01711],[@B48-ijerph-16-01711]\], and one CCT study found no difference between groups \[[@B31-ijerph-16-01711]\]. The significance level for the effect was low in all the studies (*p* ˂ 0.01).

### 3.5.3. Immune Outcomes {#sec3dot5dot3-ijerph-16-01711}

Two CCT studies included measures of immune functioning \[[@B32-ijerph-16-01711],[@B42-ijerph-16-01711]\]. They found a difference in all measures in favor of the natural environment. None of the studies reported the effect of the intervention itself, and one study did not obtain baseline measures \[[@B42-ijerph-16-01711]\].

### 3.5.4. Synthesis of Physiological Outcomes {#sec3dot5dot4-ijerph-16-01711}

The studies of endocrine and cardiovascular measures show highly heterogeneous results: the numbers of studies showing a significant decrease in pre-post measures and studies reporting no significant difference in pre-post measures and/or no significant differences between intervention and control groups were almost equal ([Figure 3](#ijerph-16-01711-f003){ref-type="fig"}). Studies without control groups \[[@B58-ijerph-16-01711],[@B59-ijerph-16-01711],[@B60-ijerph-16-01711],[@B62-ijerph-16-01711]\] were heavily represented in the measures showing significant decreases. As several of the CCT studies found significant decreases in pre-post measures of both the intervention and control and/or no significant difference between them \[[@B31-ijerph-16-01711],[@B35-ijerph-16-01711],[@B37-ijerph-16-01711],[@B39-ijerph-16-01711],[@B41-ijerph-16-01711],[@B46-ijerph-16-01711]\], the results of the pre-post studies without control groups must be questioned in terms of whether or not the positive effect was caused by exposure to the natural environment. The positive results on immune functions stem from only two studies \[[@B32-ijerph-16-01711],[@B42-ijerph-16-01711]\], one of which lacked baseline measures \[[@B42-ijerph-16-01711]\]. It is therefore impossible to draw any conclusions based on this outcome measure.

4. Discussion {#sec4-ijerph-16-01711}
=============

4.1. Quality of the Studies {#sec4dot1-ijerph-16-01711}
---------------------------

The included studies were comprised of study designs using self-referred individuals (24), many of whom were university students (10), as well as pre-post designs without randomization (15). Only three of the included studies were categorized as randomized controlled trials \[[@B27-ijerph-16-01711],[@B28-ijerph-16-01711],[@B29-ijerph-16-01711]\]. Information on several methodological aspects was generally missing in the studies. The past eight years' research into the subject must therefore be considered quite methodologically weak overall. This conclusion on the general weakness in methodology is similar to that reached in other recent reviews with slightly different scopes \[[@B6-ijerph-16-01711],[@B7-ijerph-16-01711],[@B8-ijerph-16-01711],[@B9-ijerph-16-01711],[@B10-ijerph-16-01711],[@B11-ijerph-16-01711]\], namely, that more studies using rigorous and transparent methodologies and study designs are needed. Only two studies reported effect sizes. This can be seen as a fundamental weakness in both the included studies and the review, relying solely on *p* values to evaluate the findings. As *p* values can only give information on the statistical significance of the found effect, related to the null hypotheses, and not the importance (how strong the effect is), they cannot be used to determine the therapeutic relevance of the given intervention \[[@B65-ijerph-16-01711]\]. However, one should also be aware of the potential biases when using effect sizes to perform meta-analyses on the strength of the effect across studies. It is therefore not recommended in reviews with studies assessed as weak and/or with clinical and methodological heterogeneity \[[@B63-ijerph-16-01711]\], which is the case for the present review as well as for most previous reviews.

4.2. Findings and Evidence Base {#sec4dot2-ijerph-16-01711}
-------------------------------

Based on the homogeneous, substantial, and statistically significant findings concerning emotional change, the evidence base for outdoor natural environments promoting this aspect of stress recovery seems sound. However, the limitation of being unable to determine the size of the effect and related therapeutic relevance as well as the assessment of the studies as generally weak should be taken into account. The evidence concerning the effects of exposure to nature on lowering self-perceived levels of stress is largely positive yet weak in the sense that there is a low number of studies and that the findings have low significance levels. The same applies to the evidence on various aspects of well-being and quality of life, which showed positive results but involved few studies, which themselves lacked control groups even though they had large sample sizes and high significance levels. Only one study measured recovery directly \[[@B46-ijerph-16-01711]\]. It showed a significant decrease and reported a large effect size. This could thus be an interesting measure, worthy of future research, especially given that the field seems saturated with measures of emotional change.

The evidence of the physiological effects related to stress recovery of the included past eight years' nature-based interventions is more equivocal. The synthesis showed very heterogeneous results with regard to the effect on both endocrine and cardiovascular measures and very few measures of immune functioning. Due to the findings in studies with control groups (showing effect for both the intervention and control and/or no difference), it is recommended not to conduct studies with physiological measures without control groups. There are many possible explanations as to why positive outcomes were also found in control groups. One could be that the control condition was also effective or that the measurement instruments were insufficiently sensitive to detect differences. Of course, it could also simply be related to measurement errors or inappropriate use of the measurements, as was seen in two studies using cortisol measures only twice in interventions with long time duration \[[@B28-ijerph-16-01711],[@B30-ijerph-16-01711]\] and one study using HRV as a post measure, a week after the intervention stopped \[[@B50-ijerph-16-01711]\].

The question remains why the physiological measures showed highly heterogeneous results. One explanation could be that the measures were insufficiently sensitive to capture the physiological effect of environmental exposure. Maybe there is a need to induce a stressor to detect significant physiological differences: a review of attention recovery found greater effect sizes when participants were induced with cognitively demanding tasks prior to exposure \[[@B17-ijerph-16-01711]\]. Another possibility is to raise the scientific level in the use of the physiological measures to achieve valid results. For example, take cortisol measures several times a day over the course of several days in interventions over a longer time span \[[@B64-ijerph-16-01711]\].

In addition, the relationship between psychological and physiological measures requires further study as the results are ambiguous. Studies using both measures find divergent results on psychological and physiological effects related to stress recovery.

4.3. EPHPP as Quality Assessment Tool {#sec4dot3-ijerph-16-01711}
-------------------------------------

In the present review, the EPHPP tool was chosen as it is a validated and widely used assessment tool in health research \[[@B26-ijerph-16-01711]\] and has been used in previous reviews in the field \[[@B11-ijerph-16-01711],[@B16-ijerph-16-01711]\]. In the EPHPP, the assessment of quality is based on eight parameters. However, it also includes questions on units of allocation and units of analysis as well as intervention integrity, which concerns whether there is a risk of having received an unintended intervention. These questions are not part of the quality rating. However, these aspects could cause potential bias as all studies used the individual as a unit of analysis, even though a substantial number had groups as the unit of allocation. Furthermore, the studies that had long time spans with short, repeated nature exposures had a high risk of the informants receiving an unintended intervention by factors outside the nature exposure. It is therefore recommended to use more comprehensive assessment tools to assess risk of bias in future studies, for example, the Cochrane tool for RCT studies \[[@B66-ijerph-16-01711]\] and the ROBINS-I tool for non-randomized studies \[[@B67-ijerph-16-01711]\].

4.4. "Nature-Positive" Bias {#sec4dot4-ijerph-16-01711}
---------------------------

The field is dominated by the use of self-referred subjects, who might be expected to have an interest in nature and natural environments. This could therefore have caused a potential "nature-positive" bias. Haga, Halin, Holmgreen, and Sörqvist \[[@B68-ijerph-16-01711]\] have scientifically demonstrated the "nature-positive" bias in psychological recovery in a study in which participants heard the same soundtrack while performing a cognitively demanding task. One group was told it was the sound of a waterfall, while the other was told that it was from an industrial building site. The findings showed that the "waterfall group" reported significantly more recovery than did the "building site group". As the setup in most studies in the review is built-up environments versus nature using self-referred individuals, there is strong cause for suspecting that the results are subject to "nature-positive" bias.

4.5. Limitations {#sec4dot5-ijerph-16-01711}
----------------

This review has several limitations, one concerns only including published peer-reviewed research, which one could assume favors studies with significant findings and positive effects (publication bias) \[[@B69-ijerph-16-01711]\]. The large heterogeneity and non-significant results in the reported outcomes of the physiological measures in particular, however, do not support the idea that only nature-positive studies are prone to be published. However, this is a possible limitation of the study that one must take into account. On the other hand, including non peer-reviewed studies raises other potential biases, as the peer review process can be seen as a scrutiny filter for the scientific quality \[[@B70-ijerph-16-01711]\].

Another limitation concerns the inclusion of both randomized and non-randomized studies. This is a common approach in reviews, but it presents challenges when comparing studies, and it raises the risk of bias in the non-randomized studies \[[@B19-ijerph-16-01711]\]. In addition, the limitation concerning only English language studies being included raises a limitation by possibly missing out on important studies published in other languages \[[@B20-ijerph-16-01711]\].

The greatest limitation concerns the timeframe of the review. It should be seen as a limited perspective, only covering the past eight years' research, and it raises the potential bias of studies with important contributions being published before this timeframe.

5. Conclusions {#sec5-ijerph-16-01711}
==============

The past eight years' research into psycho-physiological stress recovery in outdoors nature exposure supports the evidence of psychological effects, especially concerning emotional change. More ambiguous results were found regarding physiological effects. Therefore, the evidence base for the physiological effects of nature exposure in relation to the past eight years' research must be regarded as quite weak. The general use of self-referred individuals imposes a potential strong bias. The results of the review should be seen in relation to its limitation concerning the relatively short timeframe.
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This work was supported by the 15th of June Foundation, Denmark (grant number 2017-N-154). The foundation had no involvement in the review.

The authors declare no conflict of interest.

![Flow diagram of article-selection process.](ijerph-16-01711-g001){#ijerph-16-01711-f001}

![Synthesis of psychological outcomes of nature-based interventions. ![](ijerph-16-01711-i001.jpg) Number of studies with positive significant difference in pre-post measures of the nature intervention alone and/or effect of condition favoring the nature intervention. ![](ijerph-16-01711-i002.jpg) Number of studies with no significant difference found in pre-post measures of the nature intervention. ![](ijerph-16-01711-i003.jpg) Number of studies with positive significant difference in pre-post measures of both intervention and control and/or no significant difference between intervention and control. Note: some of the studies have several different measurement instruments and are thus represented in multiple columns in the figure.](ijerph-16-01711-g002){#ijerph-16-01711-f002}

![Synthesis of physiological outcomes of nature-based interventions. ![](ijerph-16-01711-i001.jpg) Number of studies with positive significant difference in pre-post measures of the nature intervention alone and/or effect of condition favoring the nature intervention. ![](ijerph-16-01711-i002.jpg) Number of studies with no significant difference found in pre-post measures of the nature intervention. ![](ijerph-16-01711-i003.jpg) Number of studies with positive significant difference in pre-post measures of both intervention and control and/or no significant difference between intervention and control. Note: Some of the studies have several different measurement instruments and are thus represented in multiple columns in the figure.](ijerph-16-01711-g003){#ijerph-16-01711-f003}

ijerph-16-01711-t001_Table 1

###### 

Population, intervention, comparison, and outcome variables.

  P                                                                                                                                                                       I                                                                                                                                                                  C                                                  O
  ----------------------------------------------------------------------------------------------------------------------------------------------------------------------- ------------------------------------------------------------------------------------------------------------------------------------------------------------------ -------------------------------------------------- ---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  Adults (18+), all ethnicities, all countries, with or without stress-related issues/illness, without mental disabilities or other serious physical or mental illness.   Exposure to all types of outdoors natural green environments, with all types of sedentary and light exercise activities, in all time durations. From 2010--2018.   All kinds of comparisons or no comparison group.   Physiological (cardiovascular, endocrine, and immune) and psychological (mood, physiological stress, and well-being) outcomes related to stress prevention or stress treatment.

ijerph-16-01711-t002_Table 2

###### 

Characteristics of included studies.

  Main Author, Year                                 Country       Study Design         Sample Size   Characteristics                     Age        Gender   Intervention                  Control                   Duration    Quality
  ------------------------------------------------- ------------- -------------------- ------------- ----------------------------------- ---------- -------- ----------------------------- ------------------------- ----------- ----------------
  \[[@B27-ijerph-16-01711]\] Grazuleviciene, 2016   Lithuania     RCT                  10 (10)       Coronary artery disease             45--75 y   Mixed    Park walks                    Urban walks               7 days      Weak (II)
  \[[@B28-ijerph-16-01711]\] Razani, 2018           USA           RCT 2:1 ratio        50 (28)       Low-income parents                             Mixed    Facilitated park tours        No facilitated tours      3 months    Moderate (III)
  \[[@B29-ijerph-16-01711]\] Niedermeyer, 2017      Austria       RCT crossover        42 (42)       Healthy individuals                 M:32 y     Mixed    Mountain hiking               Treadmill/sitting         3 h         Weak (II)
  \[[@B30-ijerph-16-01711]\] Han, 2016              South Korea   CCT                  14 (14)       Elderly with poor mental health     NA         NA       Horticultural therapy         Passive control           10 weeks    Weak (II)
  \[[@B31-ijerph-16-01711]\] Kjellgren, 2010        Sweden        CCT                  9 (9)         Individuals suffering from stress   37 y       Mixed    Relaxation in nature          Slideshow of nature       30 min      Moderate (II)
  \[[@B32-ijerph-16-01711]\] Mao, 2011              China         CCT                  10 (10)       University students                 NA         Male     Stay/walk in forest           Stay walk in city         2 days      Weak (I)
  \[[@B33-ijerph-16-01711]\] Largo-Wight, 2017      USA           CCT                  18 (19)       University office staff             M:49 y     Mixed    Daily outdoor break           Daily indoor break        4 weeks     Moderate (III)
  \[[@B34-ijerph-16-01711]\] Lee, 2010              Japan         CCT                  12 (12)       University students                 M:21 y     Male     Sitting in forest             Sitting in urban park     15 min      Weak (I)
  \[[@B35-ijerph-16-01711]\] Olafdottir, 2017       Iceland       CCT                  20 (24)       Inactive university students        NA         NA       Nature walk                   Treadmill/nature videos   40 min      Weak (I)
  \[[@B36-ijerph-16-01711]\] Passmore, 2014         Canada        CCT                  43 (41)       Undergraduate students              NA         Mixed    Own choice nature activity    Own choice activity       2 weeks     Weak (I)
  \[[@B37-ijerph-16-01711]\] Van den Berg, 2011     Netherlands   CCT                  14 (16)       Allotment gardeners                 38--79 y   Mixed    Gardening                     Indoor reading            30 min      Weak (II)
  \[[@B38-ijerph-16-01711]\] Fuegen, 2018           USA           CCT crossover        181 (181)     University students                 M:22 y     Mixed    Green walk/green rest         Treadmill/rest            15 min      Weak (I)
  \[[@B39-ijerph-16-01711]\] Gidlow, 2015           UK            CCT crossover        38 (38)       Unstressed adults                   M:41 y     Mixed    Green walk/blue walk          Urban walk                30 min      Weak (II)
  \[[@B40-ijerph-16-01711]\] Gladwell, 2016         UK            CCT crossover        13 (13)       Healthy individuals                 M:39 y     Mixed    Nature walk                   Campus walk               30 min      Weak (II)
  \[[@B41-ijerph-16-01711]\] Horiuchi, 2014         Japan         CCT crossover        15 (15)       Healthy volunteers                  M:36 y     Mixed    Sit and view in forest        View a curtain            15 min      Weak (I)
  \[[@B42-ijerph-16-01711]\] Im, 2016               South Korea   CCT crossover        41 (41)       Undergraduate students              18--35 y   Mixed    Forest exposure               Urban exposure            2 h         Weak (I)
  \[[@B43-ijerph-16-01711]\] Kobayashi, 2017        Japan         CCT crossover        408 (408)     Young individuals                   NA         Male     Forest viewing                Urban viewing             15 min      Weak (I)
  \[[@B44-ijerph-16-01711]\] Song, 2015             Japan         CCT crossover        23 (23)       University students                 M:22 y     Male     Park walk                     City walk                 15 min      Weak (I)
  \[[@B45-ijerph-16-01711]\] Stigsdotter, 2017      Denmark       CCT crossover        51 (51)       University students                 20--36 y   Female   View and walk in arboretum    View and walk in city     55 min      Weak (II)
  \[[@B46-ijerph-16-01711]\] Tyrväinen, 2014        Finland       CCT crossover        77 (77)       Workers in Helsinki                 30--61 y   Mixed    View and walk in woodland     View and walk in city     45 min      Moderate (III)
  \[[@B47-ijerph-16-01711]\] Berman, 2012           USA           pre/post crossover   20 (20)       Depressive disorder                 M:26 y     Mixed    Park walk                     Urban walk                50 min      Weak (I)
  \[[@B48-ijerph-16-01711]\] Li, 2016               Japan         pre/post crossover   19 (19)       Middle-aged                         40--69 y   Male     Guided walks in forest park   Urban guided walks        1 day       Weak (I)
  \[[@B49-ijerph-16-01711]\] Toda, 2013             Japan         pre/post crossover   20 (20)       Volunteers                          64--74 y   Male     Woodland walk                 Sitting in office         45 min      Weak (I)
  \[[@B50-ijerph-16-01711]\] Bang, 2017             South Korea   pre/post crossover   51 (48)       University students                 M:26 y     Mixed    Forest walk in lunch break    Passive control           6 weeks     Weak (II)
  \[[@B51-ijerph-16-01711]\] Marselle, 2014         UK            pre/post 2 groups    15 (16)       Adults                              NA         NA       Group walks in nature         Passive control           13 weeks    Moderate (III)
  \[[@B52-ijerph-16-01711]\] Bird, 2015             Australia     pre/post             20            Veterans                            31--61 y   Male     Outdoor therapy program                                 6 days      Weak (I)
  \[[@B53-ijerph-16-01711]\]Duvall, 2014            USA           pre/post             98            Veterans                            20--49 y   Mixed    Nature-based recreation                                 4--7 days   Weak (II)
  \[[@B54-ijerph-16-01711]\] Hofmann, 2017          Germany       pre/post             85            Volunteer gardeners                 25--70 y   Mixed    Urban gardening                                         6 months    Weak (II)
  \[[@B55-ijerph-16-01711]\] Iwata, 2016            Ireland       pre/post             15            Mental ill health                   32--72 y   Mixed    Forest walk                                             13 weeks    Weak (I)
  \[[@B56-ijerph-16-01711]\] Marselle, 2016         UK            pre/post             935           Elderly                             55--74 y   Mixed    Walk in nature                                          13 weeks    Weak (I)
  \[[@B57-ijerph-16-01711]\] McCaffrey, 2016        USA           pre/post             195           Adults with stress                  N/A        Mixed    Garden walks                                            6 weeks     Weak (II)
  \[[@B58-ijerph-16-01711]\] Ochiai, 2015a          Japan         pre/post             9             Normal-to-high blood pressure       40--72 y   Male     Relax and walk in forest                                1 day       Weak (I)
  \[[@B59-ijerph-16-01711]\] Ochiai, 2015b          Japan         pre/post             17            Middle aged                         40--73 y   Female   Forest therapy program                                  2 days      Weak (I)
  \[[@B60-ijerph-16-01711]\] Ohe, 2017              Japan         pre/post             43            Office workers                      20--70 y   Mixed    Forest therapy program                                  2 days      Weak (I)
  \[[@B61-ijerph-16-01711]\] Sahlin, 2015           Sweden        pre/post             57            On sick leave due to stress         45 y       Mixed    Nature-based therapy                                    16 weeks    Moderate (III)
  \[[@B62-ijerph-16-01711]\] Yu, 2017               Taiwan        pre/post             128           Middle-aged and elderly             45--86 y   Mixed    Forest bathing program                                  2 h         Weak (I)

\* The alternative quality assessment, which excludes the blinding parameter (Table 4), is included in the Quality Assessment column with the symbols I: low; II: medium; III: strong. Abbreviations. RCT: randomised controlled trial; CCT: controlled clinical trial.
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###### 

Overview of psychological measures and findings.

  Main Author, Year                                 Measure                                     Intervention            *p* Value       Control                 *p* Value   Comparison             *p* Value   Effect Size       Comments
  ------------------------------------------------- ------------------------------------------- ----------------------- --------------- ----------------------- ----------- ---------------------- ----------- ----------------- ----------------------
  **Stress, burnout, and recovery**                                                                                                                                                                                              
  **Stress**                                                                                                                                                                                                                     
  \[[@B31-ijerph-16-01711]\] Kjellgren, 2010        Stress and energy test                      NA                                      NA                                  Difference             \<0.01      NA                
  \[[@B31-ijerph-16-01711]\] Kjellgren, 2010        Stress VAS                                  NA                                      NA                                  Difference             \<0.05      NA                
  \[[@B33-ijerph-16-01711]\] Largo-Wight, 2017      Perceived stress scale                      NA                                      NA                                  Difference             \<0.05      NA                
  \[[@B38-ijerph-16-01711]\] Razani, 2018           Perceived stress scale                      NA                                      NA                                  No difference                      NA                
  \[[@B42-ijerph-16-01711]\] Im, 2016               Stress responsive inventory                 NA                                      NA                                  Difference             \<0.05      NA                No baseline
  \[[@B51-ijerph-16-01711]\] Marselle, 2014         Perceived stress scale                      NA                                      NA                                  Difference             \<0.001     0.22              
  \[[@B53-ijerph-16-01711]\] Duvall, 2014           Perceived stress scale                      NS                                                                                                             NA                
  \[[@B54-ijerph-16-01711]\] Hofmann, 2017          Stress and coping inventory                 NS                                                                                                             NA                
  **Burnout**                                                                                                                                                                                                                    
  \[[@B61-ijerph-16-01711]\] Sahlin, 2014           Shirom-melamed burnout                      Decrease                NA                                                                                     NA                
  ***Recovery***                                                                                                                                                                                                                 
  \[[@B46-ijerph-16-01711]\] Tyrväinen, 2014        Recovery outcome scale                      NA                                      NA                                  Difference             \<0.01      0.53              
  **Emotions**                                                                                                                                                                                                                   
  **Positive and negative affect**                                                                                                                                                                                               
  \[[@B27-ijerph-16-01711]\] Grazuleviciene, 2016   Positive and negative affect scale          NS                                      Decrease NA             \<0.01                                         NA                
  \[[@B35-ijerph-16-01711]\] Olafdottir, 2017       Positive and negative affect scale          NA                                      NA                                                                     NA                Results not reported
  \[[@B36-ijerph-16-01711]\] Passmore, 2014         Positive and negative affect scale          NA                                      NA                                  Difference             \<0.05      NA                
  \[[@B37-ijerph-16-01711]\] Van den Berg, 2011     Positive and negative affect scale          Increase PA             \<0.05          NS                                                                     NA                
  \[[@B38-ijerph-16-01711]\] Fuegen, 2018           Positive and negative affect scale          NA                                      NA                                  Difference             \<0.01      NA                
  \[[@B46-ijerph-16-01711]\] Tyrväinen, 2014        Positive and negative affect scale          NA                                      NA                                  Difference             \<0.01      Pa 0.43/Na 0.15   
  \[[@B47-ijerph-16-01711]\] Berman, 2012           Positive and negative affect scale          improvement             \<0.001         Improvement             \<0.005     Difference             \<0.001     NA                
  \[[@B51-ijerph-16-01711]\] Marselle, 2014         Positive and negative affect scale          NA                                      NA                                  Difference             \<0.001     Pa 0.24/Na 0.22   
  \[[@B53-ijerph-16-01711]\] Duvall, 2014           Positive and negative affect scale          Improvement             \<0.05--0.001                                                                          NA                
  \[[@B55-ijerph-16-01711]\] Iwata, 2016            Positive and negative affect scale          NS                                      NA                                                                     NA                
  \[[@B56-ijerph-16-01711]\] Marselle, 2016         Positive and negative affect scale          NA                                      NA                                  Difference             \<0.05      NA                
  **Mood**                                                                                                                                                                                                                       
  \[[@B32-ijerph-16-01711]\] Mao, 2011              Profile of mood states                      NA                                      NA                                  Difference subscales   \<0.05      NA                No baseline
  \[[@B29-ijerph-16-01711]\] Niedermeyer, 2017      Mood survey scale                           Improvement subscales   \<0.001         NS                                                                     NA                
  \[[@B34-ijerph-16-01711]\] Lee, 2010              Profile of mood states                      Improvement             \<0.01          improvement subscales   \<0.01                                         NA                
  \[[@B39-ijerph-16-01711]\] Gidlow, 2010           Profile of mood states                      NA                                      NA                                  No difference                      NA                
  \[[@B41-ijerph-16-01711]\] Horiuchi, 2014         Profile of mood states                      Improvement subscales   \<0.05-0.01     improvement subscales   \<0.01                                         NA                
  \[[@B44-ijerph-16-01711]\] Song, 2015             Profile of mood states                      NA                                      NA                                  Difference subscales   \<0.05      NA                No baseline
  \[[@B45-ijerph-16-01711]\] Stigsdotter, 2017      Profile of mood states                      Improvement             \<0.05          NS                                                                     NA                
  \[[@B48-ijerph-16-01711]\] LI, 2016               Profile of mood states                      Improvement subscales   \<0.05-0.01     Recession subscales     \<0.01                                         NA                
  \[[@B54-ijerph-16-01711]\] Hofmann, 2017          Profile of mood states                      NS                                      NS                                                                     NA                
  \[[@B58-ijerph-16-01711]\] Ochiai, 2015a          Profile of mood states                      Improvement subscales   \<0.05                                                                                 NA                
  \[[@B59-ijerph-16-01711]\] Ochiai, 2015b          Profile of mood states                      Improvement subscales   \<0.01                                                                                 NA                
  **Anxiety**                                                                                                                                                                                                                    
  \[[@B29-ijerph-16-01711]\] Niedermeyer, 2017      State trait anxiety inventory               Decrease                \<0.001         NS                                                                     NA                
  \[[@B44-ijerph-16-01711]\] Song, 2015             State trait anxiety inventory               NA                                      NA                                  Difference             \<0.01      NA                No baseline
  \[[@B61-ijerph-16-01711]\] Sahlin, 2015           Beck anxiety inventory                      Decrease                \<0.005                                                                                NA                
  \[[@B62-ijerph-16-01711]\] Yu, 2017               State trait anxiety inventory               Decrease                \<0.01                                                                                 NA                
  **Depression**                                                                                                                                                                                                                 
  \[[@B50-ijerph-16-01711]\] Bang, 2017             Beck depression inventory                   NA                                      NA                                  Difference             \<0.001     NA                
  \[[@B51-ijerph-16-01711]\] Marselle, 2014         Major depressive Inventory                  NA                                      NA                                  Difference             \<0.001     0.21              
  \[[@B55-ijerph-16-01711]\] Iwata, 2016            Hamilton depression rating scale            NA                                      NA                                                                     NA                
  \[[@B55-ijerph-16-01711]\] Iwata, 2016            Beck depression inventory                   NA                                      NA                                                                     NA                
  \[[@B61-ijerph-16-01711]\] Sahlin, 2015           Becks depression inventory                  Decrease                \<0.0001                                                                               NA                
  **Combined measures**                                                                                                                                                                                                          
  \[[@B52-ijerph-16-01711]\] Bird, 2015             Depression, anxiety, stress scale           Decrease                \<0.001                                                                                NA                
  Well-being, quality of life, and mental health                                                                                                                                                                                 
  \[[@B51-ijerph-16-01711]\] Marselle, 2014         Warwick Edinburgh mental well-being scale   NA                                      NA                                  Difference             \<0.001     0.19              
  \[[@B54-ijerph-16-01711]\] Hofmann, 2017          Mental health (SF12)                        NS                                      NS                                                                     NA                
  \[[@B56-ijerph-16-01711]\] Marselle, 2016         Single-item happiness scale                 Increase                \<0.001                                                                                NA                
  \[[@B57-ijerph-16-01711]\] McCaffrey, 2016        Personal Growth Initiative Scale (PGIS)     Increase                \<0.000                                                                                NA                
  \[[@B57-ijerph-16-01711]\] McCaffrey, 2016        Quality of Life Scale                       Increase                \<0.001                                                                                NA                
  \[[@B61-ijerph-16-01711]\] Sahlin, 2015           Psych. general well-being index             Increase                \<0.0001                                                                               NA                

Abbreviations. NA: not available; NS: not significant; ES: effect size (Confidence intervals: NA). Stress VAS: stress visual analogue scale; Pa: positive affect; Na: negative affect. Note: If a measurement instrument included both positive and negative dimensions, the term 'improved' is used if the negative has decreased and the positive increased. Only validated measurement instruments are reported in the Table.
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###### 

Overview of physiological measures and effects.

  Main Author, Year                                 Measure             Intervention   *p* Value     Control       *p* Value     Comparison       *p* Value       Comments
  ------------------------------------------------- ------------------- -------------- ------------- ------------- ------------- ---------------- --------------- -------------
  **Endocrine**                                                                                                                                                   
  **Cortisol**                                                                                                                                                    
  \[[@B27-ijerph-16-01711]\] Grazuleviciene, 2016   Salivary cortisol   NS                           NS                                                           
  \[[@B28-ijerph-16-01711]\] Razani, 2018           Serum cortisol      NA                           NA                          Difference       \<0.05          
  \[[@B30-ijerph-16-01711]\] Han, 2016              Salivary cortisol   Decrease       \<0.05        NS                                                           
  \[[@B32-ijerph-16-01711]\] Mao, 2011              Hair cortisol       NS                           NS                                                           
  \[[@B34-ijerph-16-01711]\] Lee, 2010              Salivary cortisol   NS                           NS                                                           
  \[[@B35-ijerph-16-01711]\] Olafdottir, 2017       Salivary cortisol   NA                           NA                          No difference                    
  \[[@B37-ijerph-16-01711]\] Van den Berg, 2011     Salivary cortisol   Decrease       \<0.01        Decrease      \<0.05                                         
  \[[@B39-ijerph-16-01711]\] Gidlow, 2015           Salivary cortisol   Decrease       \<0.01        Decrease      \<0.01        No difference                    
  \[[@B43-ijerph-16-01711]\] Kobayashi, 2017        Salivary cortisol   NA                           NA                          Difference       \<0.001         No baseline
  \[[@B46-ijerph-16-01711]\] Tyrväinen, 2014        Salivary cortisol   Decrease       \<0.01        Decrease      \<0.01        No difference                    
  \[[@B49-ijerph-16-01711]\] Toda, 2013             Salivary cortisol   NS                           NS                                                           
  \[[@B58-ijerph-16-01711]\] Ochiai, 2015a          Serum cortisol      Decrease       \<0.01                                                                     
  \[[@B59-ijerph-16-01711]\] Ochiai, 2015b          Salivary cortisol   Decrease       \<0.05                                                                     
  **Other**                                                                                                                                                       
  \[[@B48-ijerph-16-01711]\] Li, 2016               Stress hormones     Decrease       \<0.01        Decrease      \<0.01                                         
  \[[@B41-ijerph-16-01711]\] Horiuchi, 2014         Salivia amylases    NA                           NA                          Difference       \<0.05          
  **Cardiovascular**                                                                                                                                              
  **Heart rate variability**                                                                                                                                      
  \[[@B34-ijerph-16-01711]\] Lee, 2010              HRV                 Improved       *p* \< 0.05   NA                                                           
  \[[@B35-ijerph-16-01711]\] Olafdottir, 2017       HRV                 NA                           NA                                                           
  \[[@B39-ijerph-16-01711]\] Gidlow, 2017           HRV                 NS                           NS                                                           
  \[[@B40-ijerph-16-01711]\] Gladwell, 2016         HRV                 NA                           NA                          Difference       \<0.05          
  \[[@B41-ijerph-16-01711]\] Horiuchi, 2014         HRV                 Decrease HR    \<0.05        Decrease HR   \<0.05        No Difference                    
  \[[@B44-ijerph-16-01711]\] Song, 2015             HRV                 NA                           NA                          Difference       \<0.01          
  \[[@B45-ijerph-16-01711]\] Stigsdotter, 2017      HRV                 Increase HF    \<0.001       Increase HF   \<0.001       No difference                    
  \[[@B50-ijerph-16-01711]\] Bang, 2017             HRV                 NA                           NA                          Difference       \<0.05          
  \[[@B62-ijerph-16-01711]\] Yu, 2017               HRV                 NS                                                                                        
  **Blood pressure**                                                                                                                                              
  \[[@B27-ijerph-16-01711]\] Grazuleviciene, 2016   Blood pressure      Decrease DBP   \<0.05        NS                                                           
  \[[@B31-ijerph-16-01711]\] Kjellgren, 2010        Blood pressure      NA                           NA                          No difference                    
  \[[@B34-ijerph-16-01711]\] Lee, 2010              Blood pressure      NS                           NS                                                           
  \[[@B41-ijerph-16-01711]\] Huriuchi, 2014         Blood pressure      Decrease       *p* \< 0.05   Decrease      *p* \< 0.05   No difference                    
  \[[@B45-ijerph-16-01711]\] Stigsdotter, 2017      Blood pressure      Decrease       *p* \< 0.05   Decease       *p* \< 0.05   No difference                    
  \[[@B48-ijerph-16-01711]\] Li, 2016               Blood pressure      NS                           NS                                                           
  \[[@B49-ijerph-16-01711]\] Toda, 2013             Blood pressure      Decrease       \<0.05        NS                                                           
  \[[@B58-ijerph-16-01711]\] Ochiai, 2015a          Blood pressure      Decrease       \<0.05                                                                     
  \[[@B60-ijerph-16-01711]\] Ohe, 2017              Blood pressure      Decrease       \<0.05                                                                     
  \[[@B62-ijerph-16-01711]\] Yu, 2017               Blood pressure      Decrease       \<0.01                                                                     
  **Pulse rate**                                                                                                                                                  
  \[[@B31-ijerph-16-01711]\] Kjellgren, 2010        Pulse rate          NA                           NA                          No difference                    
  \[[@B34-ijerph-16-01711]\] Lee, 2010              Pulse rate          NA                           NA                          Difference       \<0.01          
  \[[@B48-ijerph-16-01711]\] Li, 2016               Pulse rate          NA                           NA                          Difference       \<0.01          
  \[[@B58-ijerph-16-01711]\] Ochiai, 2015a          Pulse rate          Decrease       \<0.01                                                                     
  \[[@B60-ijerph-16-01711]\] Ohe, 2017              Pulse rate          NS                                                                                        
  \[[@B62-ijerph-16-01711]\] Yu, 2017               Pulse rate          Decrease       \<0.01                                                                     
  **Immune system**                                                                                                                                               
  \[[@B32-ijerph-16-01711]\] Mao, 2011              Serum PI            NA                           NA                          Difference       \<0.05          
  \[[@B32-ijerph-16-01711]\] Mao, 2011              Oxidative stress    NA                           NA                          Difference MDA   \<0.001         
  \[[@B42-ijerph-16-01711]\] Im, 2016               Blood serum         NA                           NA                          Difference       \<0.05--0.001   No baseline

Abbreviations. NA: Not available; NS: not significant; HRV: heart rate variability; HR: heart rate; HF: high frequency; PI: pro-inflammatory; MDA: malondialdehyde. Note: If a measurement instrument involves both positive and negative dimensions, the word improved is used if the negative has decreased and the positive increased. Only validated measurement instruments are reported in the table. Only main results are reported. No effect sizes were reported; therefore this column is not entailed in the Table.
